SlideShare une entreprise Scribd logo
1  sur  34
Télécharger pour lire hors ligne
Postpartum Glucose
Screening among
homeless women with
gestational diabetes
Rie Sakai Bizmark, MD, MPH, PhD
rsakaibizmark@Lundquist.org
The dkNET Pilot Program in Bioinformatics
Webinar Series
February 24, 2023
Outline
§ Background
§ Aims and Hypotheses
§ Innovation
§ Preliminary Study
§ Data Source
§ Statistical Analyses
§ Progress
§ Future Directions
Homelessness and Health
§ On a single night in 2022, roughly 582,500 people were
experiencing homelessness in the United States.
§ people experiencing homelessness have twice the odds
of unmet medical needs related to chronic disease
compared to housed individuals
§ Limited preventive care, poor nutrition and inadequate
access to prenatal care potentially contribute to the
development of gestational diabetes mellitus (GDM)
and type 2 diabetes mellitus (TD2)
Homelessness and Pregnancy
§ Among people were experiencing homelessness in 2022,
222,970 (38.3%) were female.
§ Infancy (under age one) is the age at which a person is
most likely to experience homelessness in the US.
§ As infants are typically accompanied by their mother, this
statistic illustrates that women in the postpartum period are
also at high risk of homelessness.
More about Homelessness and
Pregnancy
§ 4% of mothers experience homelessness during
pregnancy
§ Pregnancy increases the risk of homelessness and
conversely, homelessness also increases the risk of
pregnancy.
§ Higher rates of unintended pregnancy
§ 73%, homeless vs 49%, domiciled
§ Women with a history of GDM have a nearly 10 times
higher risk of subsequently developing T2D than
women with no history of GDM
§ The American College of Obstetrics and Gynecology
(ACOG) recommend that women with GDM have a
75-g oral glucose tolerance test (OGTT) between four
and 12 weeks postpartum
§ The postpartum glucose screening (PGS) rate is
historically low despite various interventions to
improve the rate.
Relationship Between Gestational and
Type 2 Diabetes
Postpartum Glucose Screening
among Homeless
§ Commonly cited barriers to PGS
§ Cost
§ lack of access to care
§ poor communication with healthcare professionals
§ uncertain recommendations
§ lack of transportation and convenient testing locations
§ low risk awareness
§ These are also key barriers that prevent the homeless
population from seeking general preventative care
Testing Opportunities during
Healthcare Utilization
§ Providing glucose screening during any utilization of
healthcare (AUHC) within the postpartum period for
women who missed the recommended PGS screening
could be an efficient strategy for early identification of
high-risk individuals
§ AUHC includes:
1) Inpatient care
2) Emergency department visits
3) Outpatient visits
Advantages and Disadvantages of
Screening at AUHC
§ Advantages
1) Opportunity for healthcare providers and social workers
to educate homeless patients on GDM and their insurance
eligibility and coverage for the screening
2) Physical barriers to health care access are removed
§ Disadvantages
1) OGTT cannot be used because it requires fasting from
the night before
Use of RPG and A1c Tests
§ Random plasma glucose (RPG) and glycated
hemoglobin (A1c) tests
§ they can be performed quickly without fasting
§ JSDP Modification: Use of RPG and A1c as a PGS was
implemented by the Japanese Society of Diabetes
and Pregnancy (JSDP)
§ In order to reduce the risk of COVID-19 infection by
limiting time spent with medical personnel
§ Estimate rates of gestational diabetes (GDM) and
postpartum glucose screening (PGS) among homeless
women
§ Housed peers will serve as the comparison population
§ Hypothesis:
Rate of GDM is higher and rate of PGS is lower among
homeless women than housed women
AIM 1
AIM 2
§ Estimate the cost-effectiveness of providing RPG and
A1c tests during AUHC for homeless women with GDM
who missed the recommended PGS
§ Compare outcomes between the current standard of care
and the JSDP modification for those who missed PGS before
12 weeks postpartum and utilized care 12 weeks to 1 year
after delivery
§ Hypothesis:
Given the barriers faced by homeless individuals, this modified
protocol could be a cost-effective strategy for early
identification of high-risk individuals
§ AZ, CO, NC, NJ and OR
§ Medicaid claims
§ State Medicaid program: AZ, NC, and NJ
§ All Payers Claims Data (APCD): CO and OR
§ Homeless Management information system (HMIS)
§ Birth records
§ Years 2013 - 2020 chosen based on data availability
Database
We contacted 17 states, which had recorded populations of homeless
females greater than 3,000 (point-in-time count) based on the U.S.
Department of Housing and Urban Development (HUD)
Cohort selection was based on:
• Data availability
• Length of time required to process data requests
• Data quality
Data Linkage
§ Linkage between Medicaid
claims data, HMIS data, and
infant birth records will be
performed by statisticians from
state data organizations
§ Linkages will be performed using
protected patient attributes
such as social security number,
name, and birth date
§ To protect human subject
privacy, direct identifiers will be
encrypted or removed before
data delivery
§ Instead of date elements, we
requested number of days
between events
State Linkage Organization
AZ
Center for Health Information and Research (CHIR) at
Arizona State University (ASU)
CO Center for Improving Value in Health Care
NC North Carolina State Center for Health Services
NJ Trusted third party (e.g., Optum)
OR Integrated Client Services (ICS)
Innovation
§ First multi-state study to link medical and Homeless
Management Information System (HMIS) records to identify
homeless individuals
§ Some hospital records and insurance claims data have homeless
indicators, but the definition of homelessness is not consistent
across hospitals and databases
§ Utilizing the HMIS database to identify homeless individuals will
allow us to use one consistent definition of homelessness
§ We will provide the first U.S. based estimates of GDM and PGS
among homeless women
§ We will evaluate the life-long effect of the
modification in PGS
Preliminary Study (Colorado)
§ Linked Medicaid and HMIS records from Colorado
§ A total of 1,176 and 187,435 homeless and housed women delivered
babies between 2017-2019
§ Identified 83 homeless and 16,282 housed women with GDM
§ Rates and odds ratios (OR) of GDM adjusted for age and race/ethnicity
were higher among homeless (no statistical differences)
Adjusted
Rate
95%CI aORa 95%CI P value
Homeless 12.9% 10.3% 15.4% 1.16 0.92 1.46 .20
Housed 11.3% 11.1% 11.5% Reference
a:adjusted odds ratio
§ Homeless women with GDM were
more likely to be younger and non-
Hispanic White than their housed
counterparts (both Ps < .01)
§ Rates of PGS were low in both
groups of women with GDM
§ Rates higher among those who had
a postpartum checkup
§ 62.5% of homeless and 41.2% of
housed women who had a
postpartum checkup had PGS
Preliminary Study (Colorado)
Identification of Patients
§ Using linked data, we will identify women who delivered babies
between January 2014 and December 2019, and examine their
healthcare utilization (AUHC) within one year after delivery
§ The first and last possible dates for this longitudinal study will be
January 2014 and December 2020, respectively
§ Deliveries will be identified based on the International Classification
of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
diagnostic and procedure codes until September 2015, and ICD-10-
CM diagnostic and procedure codes after October 2015
Delivery
Postpartum period
1 year
Timeframe to assess AUHC
Exposure Variable: Homelessness
§ Homeless defined as individuals who stayed in shelters at
least one time during the observation period
§ Individuals who never used shelters and had valid zip codes for
their home addresses will be defined as housed individuals
§ People who utilized shelters could have been housed at
other times during the observation period, but shelter use
indicates housing insecurity
Primary Outcomes
1) Prevalence of GDM
§ Identified using ICD-9-CM 648.8 and ICD-10-CM O24.4
§ Exclusions: Pre-existing DM coded at delivery
2) PGS screening rate
§ Measured by Current Procedural Terminology (CPT) codes for
glucose tolerance test (28084-28086 and 82950-82952) and fasting
plasma glucose test (82947 and 82962)
Secondary Outcomes
1) Glucose intolerance (GI) at postpartum
§ Identified with an elevated blood glucose (ICD-9-CM 790.2 or
ICD-10-CM R73)
2) Presence of DM
§ Identified with ICD-9-CM code 250 or ICD-10-CM codes E10 or E11
in any of the diagnostic fields
Adjustment Variables
The models will be
adjusted for individual
characteristics, clinical
factors, and hospital
characteristics
Variables Explanation Source
Individual Characteristics
Age Categorized into quintile Medicaid
Race/ethnicity
Non-Hispanic White, Non-Hispanic Black, Non-Hispanic Asian
or Pacific Islander, Hispanic and other
Medicaid
Length of homelessness
We will estimate the length of homelessness from the date of
entry into housing services
HMIS
Clinical Factors
Body Mass Index
BMI will be calculated from mother’s height and weight
available in infant’s birth record
Birth
Insulin use
Women with insulin-treated GDM are more likely to follow up
than women with diet-controlled GDM
Medicaid
Maternal comorbidity
Index
Validated index score created from 21 comorbidities, such as
preeclampsia, existing diabetes mellitus (DM), multiple
gestation, hypertension, sickle cell disease, etc.
Medicaid
Hospital Characteristics
Hospital size
1] large (≥400 beds), 2] medium (100-399 beds), and 3] small
(<100 beds)
AHA
Teaching status 1] major, 2] minor, and 3] nonteaching AHA
Control type
1] investor owned and for profit, 2] nongovernment owned and
not for profit, 3] government owned and nonfederal, 4] safety-
net status (A hospital will be considered a safety-net if the
percentage of Medicaid patients was in the highest quartile for
each state. This categorization will be refined after we obtain
the database. For example, the majority of our study
population likely utilized safety-net hospitals. Therefore, it
could be categorized into two groups: 1] safety-net hospital
and 2] other.)
AHA
Location 1] urban, 2] rural AHA
Geographic location
State
Dummy variables for each state will be included (location fixed
effect). This will adjust for all location-specific time-invariant
effects
Medicaid
Statistical Analysis: AIM 1
AIM 1: Estimate rates of GDM and PGS among homeless women
§ Number of GDM and number of PGS among women who delivered
babies will be identified.
§ Multivariable logistic regression will be used to evaluate the association
between homelessness and each outcome (GDM, PGS)
§ Residual correlations are possible for the following two reasons
1] Individuals who had multiple deliveries between 2014 and 2019 will
be included in the study multiple times
2] Multiple records from the same hospitals will be included
§ Individual- and hospital-level random effects will be included
§ Cross-classified multilevel models (CCMM) will be used instead of
traditional multilevel models, which assume a structure in which
observations are hierarchically nested, e.g., individuals always had
deliveries at the same hospital
Statistical Analysis: AIM 2
AIM 2: To estimate the cost-effectiveness of providing RPG and A1c
tests during AUHC for homeless women with GDM who missed the PGS
§ Hypothetical cohort of 3,290 postpartum homeless women with
GDM
§ Compare outcomes between the current standard of care for PGS
and providing RPG and A1c tests (JSDP Modification) for those who
missed PGS before 12 weeks postpartum and utilized care 12 weeks
to 1 year after delivery
Model Structure
Decision Tree
Model Structure
1. Estimate the rate of PGS among homeless women with GDM
2. For those who were not screened, model the performance of JSDP
modification during healthcare utilization 12 weeks - 1 year after delivery
3. For those identified as having abnormal glucose metabolism by RPG and
A1c tests, perform an OGTT to confirm
4. For those with abnormal OGTT, begin intervention
Decision Tree
§ Long-term impact will be estimated using quality-adjusted life-years (QALYs)
§ Since GI also affects subsequent deliveries, the delivery rate will be
accounted for
§ Separate utilities (i.e., a measure to evaluate the relative quality of life as compared
with perfect health) will be estimated for each pregnant woman and her offspring
§ These QALYs will be summed
§ Healthy mothers and surviving offspring will be assumed to have life
expectancy of 78 years
§ Patients with treated and untreated diabetes will have their life expectancy
shortened by 8 and 9 years, respectively
§ Health risk of the offspring of a GDM mother will also be accounted for
§ All costs will be presented in 2020 U.S. dollars and adjusted based on the
medical care component of the Consumer Price Index
§ Costs and utilities will be discounted at a baseline rate of 3% based on
average inflation
§ Incremental cost-effective ratios (ICER), will be
calculated as [incremental cost]/[incremental QALYs]
Estimating Long-Term Impact
§ We also consider
§ How many people will have OGTT after they had the
abnormal results in JSDP modification test
§ How many people will stay in the intervention
§ Existing literature focusing on homeless population
showed that more than 80% of people stayed in the
intervention
§ After they develop the condition, how many people
adhere to the treatment
Parameter Estimates
§ We will use previously reported estimates for most of the
parameters, including performance of JSDP modification
(e.g., true positive/negative rates, etc.)
§ Risk adjusted rates will be estimated specifically among
postpartum homeless women with GDM using the data
(Those rates are different from the general population of
postpartum women with GDM)
§ 1] having PGS between 4 and 12 weeks after delivery
§ 2] AUHC between 12 weeks and 1 year after delivery
§ 3] a diagnosis of GI at postpartum
§ 4] delivery
Sensitivity Analyses
§ The SA will include
1) Implementation rate of having an OGTT after identified as having AGM by JSDP modification
2) Implementation rate of having the intervention after an OGTT confirmed GI
§ Parameter estimates will be altered by 50% in both directions for most inputs
§ Includes providing the JSDP modification during AUHC occurring within two years of delivery,
rather than one year
§ The following three parameter estimates, which have high uncertainty, will be altered
by 90% in the lower direction
1) Performance of the JDSP modification
Ø Performance was reported among Japanese women, but not American
2) The effect of the intervention
Ø Due to limited nutritious food options and an inadequate exercise environment, the effect of diet and
exercise counseling is likely to be smaller among homeless
3) Engagement and retention rates
§ One-way SA with Tornado plot and probabilistic SA of 1,000 simulations using Monte
Carlo simulation will be conducted
Limitations
§ Limitation #1: We will define the homeless population based on the
utilization of housing services.
§ Response: It is estimated that more than 80% of the homeless
population in the states included in this study are sheltered.
Additionally, if homeless individuals are categorized as housed, the
direction of bias will be toward the null.
§ Limitation #2: As 9.3% of the homeless population in the U.S. will be
included in the analyses, the results may not be generalizable to
other parts of the country.
§ Response: Effective postpartum care approaches for homeless
individuals can differ by state, but our approach is novel because
unmet PGS needs among the homeless have not been
reliably assessed.
§ AZ: Completed and signed the DUA
§ The data from HMIS was transferred to Center for Health Information &
Research in Arizona State University (ASU)
§ CO: Database obtained
§ NC
§ Working on DUAs with Medicaid and two HMIS
§ NJ
§ Working on DUAs
§ OR
§ Waiting for the DUA from HMIS
§ APCD wants to wait for the DUA from HMIS as their process is quick
§ MI also expressed the interest
Progress
Future Directions
§ We will perform additional cost-effectiveness analyses using other PGS
strategies
§ For example, providing an OGTT during the delivery hospitalization when
postpartum follow-up is challenging
§ We will collaborate with stakeholders in the local area to develop
strategies to increase the utilization of PGS
§ We will evaluate other healthcare interventions
§ For example, efforts to increase the diabetic retinopathy screening rate
Thank you
Any questions or comments?
rsakaibizmark@lundquist.org

Contenu connexe

Similaire à dkNET Webinar: Postpartum Glucose Screening Among Homeless Women with Gestational Diabetes 02/24/2023

Alternate Level of Care Experience in High-Risk Older Adults in New Brunswick...
Alternate Level of Care Experience in High-Risk Older Adults in New Brunswick...Alternate Level of Care Experience in High-Risk Older Adults in New Brunswick...
Alternate Level of Care Experience in High-Risk Older Adults in New Brunswick...
DataNB
 
Stm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refsStm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refs
monkmartinez
 

Similaire à dkNET Webinar: Postpartum Glucose Screening Among Homeless Women with Gestational Diabetes 02/24/2023 (20)

Schold
ScholdSchold
Schold
 
MyRISQ
MyRISQMyRISQ
MyRISQ
 
2017 elsi congress panel meyer only
2017 elsi congress panel   meyer only2017 elsi congress panel   meyer only
2017 elsi congress panel meyer only
 
Community Perspective on Healthcare Panel: Dr. Boyle
Community Perspective on Healthcare Panel: Dr. Boyle Community Perspective on Healthcare Panel: Dr. Boyle
Community Perspective on Healthcare Panel: Dr. Boyle
 
Alternate Level of Care Experience in High-Risk Older Adults in New Brunswick...
Alternate Level of Care Experience in High-Risk Older Adults in New Brunswick...Alternate Level of Care Experience in High-Risk Older Adults in New Brunswick...
Alternate Level of Care Experience in High-Risk Older Adults in New Brunswick...
 
Women's Access to Healthcare - GA Dept. of Public Health Presentation
Women's Access to Healthcare - GA Dept. of Public Health PresentationWomen's Access to Healthcare - GA Dept. of Public Health Presentation
Women's Access to Healthcare - GA Dept. of Public Health Presentation
 
CRC Screening Recommendations Download.pptx
CRC Screening Recommendations Download.pptxCRC Screening Recommendations Download.pptx
CRC Screening Recommendations Download.pptx
 
Global prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptx
Global prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptxGlobal prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptx
Global prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptx
 
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
 
Newborn Screening: Part III
Newborn Screening: Part IIINewborn Screening: Part III
Newborn Screening: Part III
 
Sleep Quality and Quality of Life in Adults with Type 2 Diabetes
Sleep Quality and Quality of Life in Adults with Type 2 DiabetesSleep Quality and Quality of Life in Adults with Type 2 Diabetes
Sleep Quality and Quality of Life in Adults with Type 2 Diabetes
 
Addressing Genetics Workforce Shortage - April 11, 2023
Addressing Genetics Workforce Shortage - April 11, 2023Addressing Genetics Workforce Shortage - April 11, 2023
Addressing Genetics Workforce Shortage - April 11, 2023
 
Komen Webinar on Genetics and Breast Cancer
Komen Webinar on Genetics and Breast CancerKomen Webinar on Genetics and Breast Cancer
Komen Webinar on Genetics and Breast Cancer
 
Risk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskApps Risk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskApps
 
Risk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskAppsRisk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskApps
 
My Personal Odyssey with Big Data - Brad Popovich
My Personal Odyssey with Big Data - Brad PopovichMy Personal Odyssey with Big Data - Brad Popovich
My Personal Odyssey with Big Data - Brad Popovich
 
State Of Illinois Diabetes Commission Presentation
State Of Illinois Diabetes Commission PresentationState Of Illinois Diabetes Commission Presentation
State Of Illinois Diabetes Commission Presentation
 
When reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparitiesWhen reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparities
 
Stm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refsStm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refs
 
Public Health HIV/STD Control in the US in the Era of TASP: 90-90-90 and Beyond
Public Health HIV/STD Control in the US in the Era of TASP: 90-90-90 and BeyondPublic Health HIV/STD Control in the US in the Era of TASP: 90-90-90 and Beyond
Public Health HIV/STD Control in the US in the Era of TASP: 90-90-90 and Beyond
 

Plus de dkNET

dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
dkNET
 
dkNET Webinar: Tabula Sapiens 03/22/2024
dkNET Webinar: Tabula Sapiens 03/22/2024dkNET Webinar: Tabula Sapiens 03/22/2024
dkNET Webinar: Tabula Sapiens 03/22/2024
dkNET
 
dkNET Webinar "The Multi-Omic Response to Exercise Training Across Rat Tissue...
dkNET Webinar "The Multi-Omic Response to Exercise Training Across Rat Tissue...dkNET Webinar "The Multi-Omic Response to Exercise Training Across Rat Tissue...
dkNET Webinar "The Multi-Omic Response to Exercise Training Across Rat Tissue...
dkNET
 
dkNET Webinar: The Collaborative Microbial Metabolite Center – Democratizing ...
dkNET Webinar: The Collaborative Microbial Metabolite Center – Democratizing ...dkNET Webinar: The Collaborative Microbial Metabolite Center – Democratizing ...
dkNET Webinar: The Collaborative Microbial Metabolite Center – Democratizing ...
dkNET
 
dkNET Webinar: An Encyclopedia of the Adipose Tissue Secretome to Identify Me...
dkNET Webinar: An Encyclopedia of the Adipose Tissue Secretome to Identify Me...dkNET Webinar: An Encyclopedia of the Adipose Tissue Secretome to Identify Me...
dkNET Webinar: An Encyclopedia of the Adipose Tissue Secretome to Identify Me...
dkNET
 
dkNET Webinar: A Single Cell Atlas of Human and Mouse White Adipose Tissue 11...
dkNET Webinar: A Single Cell Atlas of Human and Mouse White Adipose Tissue 11...dkNET Webinar: A Single Cell Atlas of Human and Mouse White Adipose Tissue 11...
dkNET Webinar: A Single Cell Atlas of Human and Mouse White Adipose Tissue 11...
dkNET
 
dkNET Webinar "The National Sleep Research Resource (NSRR) - Opportunities fo...
dkNET Webinar "The National Sleep Research Resource (NSRR) - Opportunities fo...dkNET Webinar "The National Sleep Research Resource (NSRR) - Opportunities fo...
dkNET Webinar "The National Sleep Research Resource (NSRR) - Opportunities fo...
dkNET
 
dkNET Webinar: Discover the Latest from dkNET - Biomed Resource Watch 06/02/2023
dkNET Webinar: Discover the Latest from dkNET - Biomed Resource Watch 06/02/2023dkNET Webinar: Discover the Latest from dkNET - Biomed Resource Watch 06/02/2023
dkNET Webinar: Discover the Latest from dkNET - Biomed Resource Watch 06/02/2023
dkNET
 
dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabete...
dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabete...dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabete...
dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabete...
dkNET
 
dkNET Webinar: Estimating Relative Beta-Cell Function During Continuous Gluco...
dkNET Webinar: Estimating Relative Beta-Cell Function During Continuous Gluco...dkNET Webinar: Estimating Relative Beta-Cell Function During Continuous Gluco...
dkNET Webinar: Estimating Relative Beta-Cell Function During Continuous Gluco...
dkNET
 
dkNET Webinar: Choosing Sample Sizes for Multilevel and Longitudinal Studies ...
dkNET Webinar: Choosing Sample Sizes for Multilevel and Longitudinal Studies ...dkNET Webinar: Choosing Sample Sizes for Multilevel and Longitudinal Studies ...
dkNET Webinar: Choosing Sample Sizes for Multilevel and Longitudinal Studies ...
dkNET
 
dkNET Webinar: : FAIR Data Curation of Antibody/B-cell and T-cell Receptor Se...
dkNET Webinar: : FAIR Data Curation of Antibody/B-cell and T-cell Receptor Se...dkNET Webinar: : FAIR Data Curation of Antibody/B-cell and T-cell Receptor Se...
dkNET Webinar: : FAIR Data Curation of Antibody/B-cell and T-cell Receptor Se...
dkNET
 
dkNET Webinar "The Mission and Progress of the(sugar)science: Helping Scienti...
dkNET Webinar "The Mission and Progress of the(sugar)science: Helping Scienti...dkNET Webinar "The Mission and Progress of the(sugar)science: Helping Scienti...
dkNET Webinar "The Mission and Progress of the(sugar)science: Helping Scienti...
dkNET
 
dkNET Webinar: Discovering and Evaluating Antibodies, Cell Lines, Software To...
dkNET Webinar: Discovering and Evaluating Antibodies, Cell Lines, Software To...dkNET Webinar: Discovering and Evaluating Antibodies, Cell Lines, Software To...
dkNET Webinar: Discovering and Evaluating Antibodies, Cell Lines, Software To...
dkNET
 

Plus de dkNET (20)

dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...
dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...
dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...
 
dkNET Office Hours: NIH Data Management and Sharing Mandate 05/03/2024
dkNET Office Hours: NIH Data Management and Sharing Mandate  05/03/2024dkNET Office Hours: NIH Data Management and Sharing Mandate  05/03/2024
dkNET Office Hours: NIH Data Management and Sharing Mandate 05/03/2024
 
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
 
dkNET Webinar: Unlocking the Power of FAIR Data Sharing with ImmPort 04/12/2024
dkNET Webinar: Unlocking the Power of FAIR Data Sharing with ImmPort 04/12/2024dkNET Webinar: Unlocking the Power of FAIR Data Sharing with ImmPort 04/12/2024
dkNET Webinar: Unlocking the Power of FAIR Data Sharing with ImmPort 04/12/2024
 
dkNET Webinar: Tabula Sapiens 03/22/2024
dkNET Webinar: Tabula Sapiens 03/22/2024dkNET Webinar: Tabula Sapiens 03/22/2024
dkNET Webinar: Tabula Sapiens 03/22/2024
 
dkNET Webinar "The Multi-Omic Response to Exercise Training Across Rat Tissue...
dkNET Webinar "The Multi-Omic Response to Exercise Training Across Rat Tissue...dkNET Webinar "The Multi-Omic Response to Exercise Training Across Rat Tissue...
dkNET Webinar "The Multi-Omic Response to Exercise Training Across Rat Tissue...
 
dkNET Webinar: The Collaborative Microbial Metabolite Center – Democratizing ...
dkNET Webinar: The Collaborative Microbial Metabolite Center – Democratizing ...dkNET Webinar: The Collaborative Microbial Metabolite Center – Democratizing ...
dkNET Webinar: The Collaborative Microbial Metabolite Center – Democratizing ...
 
dkNET Webinar: An Encyclopedia of the Adipose Tissue Secretome to Identify Me...
dkNET Webinar: An Encyclopedia of the Adipose Tissue Secretome to Identify Me...dkNET Webinar: An Encyclopedia of the Adipose Tissue Secretome to Identify Me...
dkNET Webinar: An Encyclopedia of the Adipose Tissue Secretome to Identify Me...
 
dkNET Webinar: A Single Cell Atlas of Human and Mouse White Adipose Tissue 11...
dkNET Webinar: A Single Cell Atlas of Human and Mouse White Adipose Tissue 11...dkNET Webinar: A Single Cell Atlas of Human and Mouse White Adipose Tissue 11...
dkNET Webinar: A Single Cell Atlas of Human and Mouse White Adipose Tissue 11...
 
dkNET Webinar "The National Sleep Research Resource (NSRR) - Opportunities fo...
dkNET Webinar "The National Sleep Research Resource (NSRR) - Opportunities fo...dkNET Webinar "The National Sleep Research Resource (NSRR) - Opportunities fo...
dkNET Webinar "The National Sleep Research Resource (NSRR) - Opportunities fo...
 
dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sha...
dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sha...dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sha...
dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sha...
 
dkNET Webinar: Discover the Latest from dkNET - Biomed Resource Watch 06/02/2023
dkNET Webinar: Discover the Latest from dkNET - Biomed Resource Watch 06/02/2023dkNET Webinar: Discover the Latest from dkNET - Biomed Resource Watch 06/02/2023
dkNET Webinar: Discover the Latest from dkNET - Biomed Resource Watch 06/02/2023
 
dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabete...
dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabete...dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabete...
dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabete...
 
dkNET Webinar: Estimating Relative Beta-Cell Function During Continuous Gluco...
dkNET Webinar: Estimating Relative Beta-Cell Function During Continuous Gluco...dkNET Webinar: Estimating Relative Beta-Cell Function During Continuous Gluco...
dkNET Webinar: Estimating Relative Beta-Cell Function During Continuous Gluco...
 
dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sha...
dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sha...dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sha...
dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sha...
 
dkNET Webinar: Choosing Sample Sizes for Multilevel and Longitudinal Studies ...
dkNET Webinar: Choosing Sample Sizes for Multilevel and Longitudinal Studies ...dkNET Webinar: Choosing Sample Sizes for Multilevel and Longitudinal Studies ...
dkNET Webinar: Choosing Sample Sizes for Multilevel and Longitudinal Studies ...
 
dkNET Webinar: : FAIR Data Curation of Antibody/B-cell and T-cell Receptor Se...
dkNET Webinar: : FAIR Data Curation of Antibody/B-cell and T-cell Receptor Se...dkNET Webinar: : FAIR Data Curation of Antibody/B-cell and T-cell Receptor Se...
dkNET Webinar: : FAIR Data Curation of Antibody/B-cell and T-cell Receptor Se...
 
dkNET Office Hours - "Are You Ready for 2023? New NIH Data Management and Sha...
dkNET Office Hours - "Are You Ready for 2023? New NIH Data Management and Sha...dkNET Office Hours - "Are You Ready for 2023? New NIH Data Management and Sha...
dkNET Office Hours - "Are You Ready for 2023? New NIH Data Management and Sha...
 
dkNET Webinar "The Mission and Progress of the(sugar)science: Helping Scienti...
dkNET Webinar "The Mission and Progress of the(sugar)science: Helping Scienti...dkNET Webinar "The Mission and Progress of the(sugar)science: Helping Scienti...
dkNET Webinar "The Mission and Progress of the(sugar)science: Helping Scienti...
 
dkNET Webinar: Discovering and Evaluating Antibodies, Cell Lines, Software To...
dkNET Webinar: Discovering and Evaluating Antibodies, Cell Lines, Software To...dkNET Webinar: Discovering and Evaluating Antibodies, Cell Lines, Software To...
dkNET Webinar: Discovering and Evaluating Antibodies, Cell Lines, Software To...
 

Dernier

Isolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptxIsolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptx
GOWTHAMIM22
 
Quantifying Artificial Intelligence and What Comes Next!
Quantifying Artificial Intelligence and What Comes Next!Quantifying Artificial Intelligence and What Comes Next!
Quantifying Artificial Intelligence and What Comes Next!
University of Hertfordshire
 
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
Tuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notesTuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notes
jyothisaisri
 

Dernier (20)

Isolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptxIsolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptx
 
Heads-Up Multitasker: CHI 2024 Presentation.pdf
Heads-Up Multitasker: CHI 2024 Presentation.pdfHeads-Up Multitasker: CHI 2024 Presentation.pdf
Heads-Up Multitasker: CHI 2024 Presentation.pdf
 
WASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 Rp
WASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 RpWASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 Rp
WASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 Rp
 
Extensive Pollution of Uranus and Neptune’s Atmospheres by Upsweep of Icy Mat...
Extensive Pollution of Uranus and Neptune’s Atmospheres by Upsweep of Icy Mat...Extensive Pollution of Uranus and Neptune’s Atmospheres by Upsweep of Icy Mat...
Extensive Pollution of Uranus and Neptune’s Atmospheres by Upsweep of Icy Mat...
 
RACEMIzATION AND ISOMERISATION completed.pptx
RACEMIzATION AND ISOMERISATION completed.pptxRACEMIzATION AND ISOMERISATION completed.pptx
RACEMIzATION AND ISOMERISATION completed.pptx
 
GBSN - Biochemistry (Unit 8) Enzymology
GBSN - Biochemistry (Unit 8) EnzymologyGBSN - Biochemistry (Unit 8) Enzymology
GBSN - Biochemistry (Unit 8) Enzymology
 
Alternative method of dissolution in-vitro in-vivo correlation and dissolutio...
Alternative method of dissolution in-vitro in-vivo correlation and dissolutio...Alternative method of dissolution in-vitro in-vivo correlation and dissolutio...
Alternative method of dissolution in-vitro in-vivo correlation and dissolutio...
 
MODERN PHYSICS_REPORTING_QUANTA_.....pdf
MODERN PHYSICS_REPORTING_QUANTA_.....pdfMODERN PHYSICS_REPORTING_QUANTA_.....pdf
MODERN PHYSICS_REPORTING_QUANTA_.....pdf
 
Quantifying Artificial Intelligence and What Comes Next!
Quantifying Artificial Intelligence and What Comes Next!Quantifying Artificial Intelligence and What Comes Next!
Quantifying Artificial Intelligence and What Comes Next!
 
Introduction and significance of Symbiotic algae
Introduction and significance of  Symbiotic algaeIntroduction and significance of  Symbiotic algae
Introduction and significance of Symbiotic algae
 
GBSN - Microbiology (Unit 7) Microbiology in Everyday Life
GBSN - Microbiology (Unit 7) Microbiology in Everyday LifeGBSN - Microbiology (Unit 7) Microbiology in Everyday Life
GBSN - Microbiology (Unit 7) Microbiology in Everyday Life
 
Biochemistry and Biomolecules - Science - 9th Grade by Slidesgo.pptx
Biochemistry and Biomolecules - Science - 9th Grade by Slidesgo.pptxBiochemistry and Biomolecules - Science - 9th Grade by Slidesgo.pptx
Biochemistry and Biomolecules - Science - 9th Grade by Slidesgo.pptx
 
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
 
Manganese‐RichSandstonesasanIndicatorofAncientOxic LakeWaterConditionsinGale...
Manganese‐RichSandstonesasanIndicatorofAncientOxic  LakeWaterConditionsinGale...Manganese‐RichSandstonesasanIndicatorofAncientOxic  LakeWaterConditionsinGale...
Manganese‐RichSandstonesasanIndicatorofAncientOxic LakeWaterConditionsinGale...
 
PHOTOSYNTHETIC BACTERIA (OXYGENIC AND ANOXYGENIC)
PHOTOSYNTHETIC BACTERIA  (OXYGENIC AND ANOXYGENIC)PHOTOSYNTHETIC BACTERIA  (OXYGENIC AND ANOXYGENIC)
PHOTOSYNTHETIC BACTERIA (OXYGENIC AND ANOXYGENIC)
 
Factor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary GlandFactor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary Gland
 
Tuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notesTuberculosis (TB)-Notes.pdf microbiology notes
Tuberculosis (TB)-Notes.pdf microbiology notes
 
NuGOweek 2024 programme final FLYER short.pdf
NuGOweek 2024 programme final FLYER short.pdfNuGOweek 2024 programme final FLYER short.pdf
NuGOweek 2024 programme final FLYER short.pdf
 
Triploidy ...............................pptx
Triploidy ...............................pptxTriploidy ...............................pptx
Triploidy ...............................pptx
 
Lubrication System in forced feed system
Lubrication System in forced feed systemLubrication System in forced feed system
Lubrication System in forced feed system
 

dkNET Webinar: Postpartum Glucose Screening Among Homeless Women with Gestational Diabetes 02/24/2023

  • 1. Postpartum Glucose Screening among homeless women with gestational diabetes Rie Sakai Bizmark, MD, MPH, PhD rsakaibizmark@Lundquist.org The dkNET Pilot Program in Bioinformatics Webinar Series February 24, 2023
  • 2. Outline § Background § Aims and Hypotheses § Innovation § Preliminary Study § Data Source § Statistical Analyses § Progress § Future Directions
  • 3. Homelessness and Health § On a single night in 2022, roughly 582,500 people were experiencing homelessness in the United States. § people experiencing homelessness have twice the odds of unmet medical needs related to chronic disease compared to housed individuals § Limited preventive care, poor nutrition and inadequate access to prenatal care potentially contribute to the development of gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (TD2)
  • 4. Homelessness and Pregnancy § Among people were experiencing homelessness in 2022, 222,970 (38.3%) were female. § Infancy (under age one) is the age at which a person is most likely to experience homelessness in the US. § As infants are typically accompanied by their mother, this statistic illustrates that women in the postpartum period are also at high risk of homelessness.
  • 5. More about Homelessness and Pregnancy § 4% of mothers experience homelessness during pregnancy § Pregnancy increases the risk of homelessness and conversely, homelessness also increases the risk of pregnancy. § Higher rates of unintended pregnancy § 73%, homeless vs 49%, domiciled
  • 6. § Women with a history of GDM have a nearly 10 times higher risk of subsequently developing T2D than women with no history of GDM § The American College of Obstetrics and Gynecology (ACOG) recommend that women with GDM have a 75-g oral glucose tolerance test (OGTT) between four and 12 weeks postpartum § The postpartum glucose screening (PGS) rate is historically low despite various interventions to improve the rate. Relationship Between Gestational and Type 2 Diabetes
  • 7. Postpartum Glucose Screening among Homeless § Commonly cited barriers to PGS § Cost § lack of access to care § poor communication with healthcare professionals § uncertain recommendations § lack of transportation and convenient testing locations § low risk awareness § These are also key barriers that prevent the homeless population from seeking general preventative care
  • 8. Testing Opportunities during Healthcare Utilization § Providing glucose screening during any utilization of healthcare (AUHC) within the postpartum period for women who missed the recommended PGS screening could be an efficient strategy for early identification of high-risk individuals § AUHC includes: 1) Inpatient care 2) Emergency department visits 3) Outpatient visits
  • 9. Advantages and Disadvantages of Screening at AUHC § Advantages 1) Opportunity for healthcare providers and social workers to educate homeless patients on GDM and their insurance eligibility and coverage for the screening 2) Physical barriers to health care access are removed § Disadvantages 1) OGTT cannot be used because it requires fasting from the night before
  • 10. Use of RPG and A1c Tests § Random plasma glucose (RPG) and glycated hemoglobin (A1c) tests § they can be performed quickly without fasting § JSDP Modification: Use of RPG and A1c as a PGS was implemented by the Japanese Society of Diabetes and Pregnancy (JSDP) § In order to reduce the risk of COVID-19 infection by limiting time spent with medical personnel
  • 11. § Estimate rates of gestational diabetes (GDM) and postpartum glucose screening (PGS) among homeless women § Housed peers will serve as the comparison population § Hypothesis: Rate of GDM is higher and rate of PGS is lower among homeless women than housed women AIM 1
  • 12. AIM 2 § Estimate the cost-effectiveness of providing RPG and A1c tests during AUHC for homeless women with GDM who missed the recommended PGS § Compare outcomes between the current standard of care and the JSDP modification for those who missed PGS before 12 weeks postpartum and utilized care 12 weeks to 1 year after delivery § Hypothesis: Given the barriers faced by homeless individuals, this modified protocol could be a cost-effective strategy for early identification of high-risk individuals
  • 13. § AZ, CO, NC, NJ and OR § Medicaid claims § State Medicaid program: AZ, NC, and NJ § All Payers Claims Data (APCD): CO and OR § Homeless Management information system (HMIS) § Birth records § Years 2013 - 2020 chosen based on data availability Database We contacted 17 states, which had recorded populations of homeless females greater than 3,000 (point-in-time count) based on the U.S. Department of Housing and Urban Development (HUD) Cohort selection was based on: • Data availability • Length of time required to process data requests • Data quality
  • 14. Data Linkage § Linkage between Medicaid claims data, HMIS data, and infant birth records will be performed by statisticians from state data organizations § Linkages will be performed using protected patient attributes such as social security number, name, and birth date § To protect human subject privacy, direct identifiers will be encrypted or removed before data delivery § Instead of date elements, we requested number of days between events State Linkage Organization AZ Center for Health Information and Research (CHIR) at Arizona State University (ASU) CO Center for Improving Value in Health Care NC North Carolina State Center for Health Services NJ Trusted third party (e.g., Optum) OR Integrated Client Services (ICS)
  • 15. Innovation § First multi-state study to link medical and Homeless Management Information System (HMIS) records to identify homeless individuals § Some hospital records and insurance claims data have homeless indicators, but the definition of homelessness is not consistent across hospitals and databases § Utilizing the HMIS database to identify homeless individuals will allow us to use one consistent definition of homelessness § We will provide the first U.S. based estimates of GDM and PGS among homeless women § We will evaluate the life-long effect of the modification in PGS
  • 16. Preliminary Study (Colorado) § Linked Medicaid and HMIS records from Colorado § A total of 1,176 and 187,435 homeless and housed women delivered babies between 2017-2019 § Identified 83 homeless and 16,282 housed women with GDM § Rates and odds ratios (OR) of GDM adjusted for age and race/ethnicity were higher among homeless (no statistical differences) Adjusted Rate 95%CI aORa 95%CI P value Homeless 12.9% 10.3% 15.4% 1.16 0.92 1.46 .20 Housed 11.3% 11.1% 11.5% Reference a:adjusted odds ratio
  • 17. § Homeless women with GDM were more likely to be younger and non- Hispanic White than their housed counterparts (both Ps < .01) § Rates of PGS were low in both groups of women with GDM § Rates higher among those who had a postpartum checkup § 62.5% of homeless and 41.2% of housed women who had a postpartum checkup had PGS Preliminary Study (Colorado)
  • 18. Identification of Patients § Using linked data, we will identify women who delivered babies between January 2014 and December 2019, and examine their healthcare utilization (AUHC) within one year after delivery § The first and last possible dates for this longitudinal study will be January 2014 and December 2020, respectively § Deliveries will be identified based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnostic and procedure codes until September 2015, and ICD-10- CM diagnostic and procedure codes after October 2015 Delivery Postpartum period 1 year Timeframe to assess AUHC
  • 19. Exposure Variable: Homelessness § Homeless defined as individuals who stayed in shelters at least one time during the observation period § Individuals who never used shelters and had valid zip codes for their home addresses will be defined as housed individuals § People who utilized shelters could have been housed at other times during the observation period, but shelter use indicates housing insecurity
  • 20. Primary Outcomes 1) Prevalence of GDM § Identified using ICD-9-CM 648.8 and ICD-10-CM O24.4 § Exclusions: Pre-existing DM coded at delivery 2) PGS screening rate § Measured by Current Procedural Terminology (CPT) codes for glucose tolerance test (28084-28086 and 82950-82952) and fasting plasma glucose test (82947 and 82962)
  • 21. Secondary Outcomes 1) Glucose intolerance (GI) at postpartum § Identified with an elevated blood glucose (ICD-9-CM 790.2 or ICD-10-CM R73) 2) Presence of DM § Identified with ICD-9-CM code 250 or ICD-10-CM codes E10 or E11 in any of the diagnostic fields
  • 22. Adjustment Variables The models will be adjusted for individual characteristics, clinical factors, and hospital characteristics Variables Explanation Source Individual Characteristics Age Categorized into quintile Medicaid Race/ethnicity Non-Hispanic White, Non-Hispanic Black, Non-Hispanic Asian or Pacific Islander, Hispanic and other Medicaid Length of homelessness We will estimate the length of homelessness from the date of entry into housing services HMIS Clinical Factors Body Mass Index BMI will be calculated from mother’s height and weight available in infant’s birth record Birth Insulin use Women with insulin-treated GDM are more likely to follow up than women with diet-controlled GDM Medicaid Maternal comorbidity Index Validated index score created from 21 comorbidities, such as preeclampsia, existing diabetes mellitus (DM), multiple gestation, hypertension, sickle cell disease, etc. Medicaid Hospital Characteristics Hospital size 1] large (≥400 beds), 2] medium (100-399 beds), and 3] small (<100 beds) AHA Teaching status 1] major, 2] minor, and 3] nonteaching AHA Control type 1] investor owned and for profit, 2] nongovernment owned and not for profit, 3] government owned and nonfederal, 4] safety- net status (A hospital will be considered a safety-net if the percentage of Medicaid patients was in the highest quartile for each state. This categorization will be refined after we obtain the database. For example, the majority of our study population likely utilized safety-net hospitals. Therefore, it could be categorized into two groups: 1] safety-net hospital and 2] other.) AHA Location 1] urban, 2] rural AHA Geographic location State Dummy variables for each state will be included (location fixed effect). This will adjust for all location-specific time-invariant effects Medicaid
  • 23. Statistical Analysis: AIM 1 AIM 1: Estimate rates of GDM and PGS among homeless women § Number of GDM and number of PGS among women who delivered babies will be identified. § Multivariable logistic regression will be used to evaluate the association between homelessness and each outcome (GDM, PGS) § Residual correlations are possible for the following two reasons 1] Individuals who had multiple deliveries between 2014 and 2019 will be included in the study multiple times 2] Multiple records from the same hospitals will be included § Individual- and hospital-level random effects will be included § Cross-classified multilevel models (CCMM) will be used instead of traditional multilevel models, which assume a structure in which observations are hierarchically nested, e.g., individuals always had deliveries at the same hospital
  • 24. Statistical Analysis: AIM 2 AIM 2: To estimate the cost-effectiveness of providing RPG and A1c tests during AUHC for homeless women with GDM who missed the PGS § Hypothetical cohort of 3,290 postpartum homeless women with GDM § Compare outcomes between the current standard of care for PGS and providing RPG and A1c tests (JSDP Modification) for those who missed PGS before 12 weeks postpartum and utilized care 12 weeks to 1 year after delivery
  • 26. Model Structure 1. Estimate the rate of PGS among homeless women with GDM 2. For those who were not screened, model the performance of JSDP modification during healthcare utilization 12 weeks - 1 year after delivery 3. For those identified as having abnormal glucose metabolism by RPG and A1c tests, perform an OGTT to confirm 4. For those with abnormal OGTT, begin intervention Decision Tree
  • 27. § Long-term impact will be estimated using quality-adjusted life-years (QALYs) § Since GI also affects subsequent deliveries, the delivery rate will be accounted for § Separate utilities (i.e., a measure to evaluate the relative quality of life as compared with perfect health) will be estimated for each pregnant woman and her offspring § These QALYs will be summed § Healthy mothers and surviving offspring will be assumed to have life expectancy of 78 years § Patients with treated and untreated diabetes will have their life expectancy shortened by 8 and 9 years, respectively § Health risk of the offspring of a GDM mother will also be accounted for § All costs will be presented in 2020 U.S. dollars and adjusted based on the medical care component of the Consumer Price Index § Costs and utilities will be discounted at a baseline rate of 3% based on average inflation § Incremental cost-effective ratios (ICER), will be calculated as [incremental cost]/[incremental QALYs] Estimating Long-Term Impact
  • 28. § We also consider § How many people will have OGTT after they had the abnormal results in JSDP modification test § How many people will stay in the intervention § Existing literature focusing on homeless population showed that more than 80% of people stayed in the intervention § After they develop the condition, how many people adhere to the treatment
  • 29. Parameter Estimates § We will use previously reported estimates for most of the parameters, including performance of JSDP modification (e.g., true positive/negative rates, etc.) § Risk adjusted rates will be estimated specifically among postpartum homeless women with GDM using the data (Those rates are different from the general population of postpartum women with GDM) § 1] having PGS between 4 and 12 weeks after delivery § 2] AUHC between 12 weeks and 1 year after delivery § 3] a diagnosis of GI at postpartum § 4] delivery
  • 30. Sensitivity Analyses § The SA will include 1) Implementation rate of having an OGTT after identified as having AGM by JSDP modification 2) Implementation rate of having the intervention after an OGTT confirmed GI § Parameter estimates will be altered by 50% in both directions for most inputs § Includes providing the JSDP modification during AUHC occurring within two years of delivery, rather than one year § The following three parameter estimates, which have high uncertainty, will be altered by 90% in the lower direction 1) Performance of the JDSP modification Ø Performance was reported among Japanese women, but not American 2) The effect of the intervention Ø Due to limited nutritious food options and an inadequate exercise environment, the effect of diet and exercise counseling is likely to be smaller among homeless 3) Engagement and retention rates § One-way SA with Tornado plot and probabilistic SA of 1,000 simulations using Monte Carlo simulation will be conducted
  • 31. Limitations § Limitation #1: We will define the homeless population based on the utilization of housing services. § Response: It is estimated that more than 80% of the homeless population in the states included in this study are sheltered. Additionally, if homeless individuals are categorized as housed, the direction of bias will be toward the null. § Limitation #2: As 9.3% of the homeless population in the U.S. will be included in the analyses, the results may not be generalizable to other parts of the country. § Response: Effective postpartum care approaches for homeless individuals can differ by state, but our approach is novel because unmet PGS needs among the homeless have not been reliably assessed.
  • 32. § AZ: Completed and signed the DUA § The data from HMIS was transferred to Center for Health Information & Research in Arizona State University (ASU) § CO: Database obtained § NC § Working on DUAs with Medicaid and two HMIS § NJ § Working on DUAs § OR § Waiting for the DUA from HMIS § APCD wants to wait for the DUA from HMIS as their process is quick § MI also expressed the interest Progress
  • 33. Future Directions § We will perform additional cost-effectiveness analyses using other PGS strategies § For example, providing an OGTT during the delivery hospitalization when postpartum follow-up is challenging § We will collaborate with stakeholders in the local area to develop strategies to increase the utilization of PGS § We will evaluate other healthcare interventions § For example, efforts to increase the diabetic retinopathy screening rate
  • 34. Thank you Any questions or comments? rsakaibizmark@lundquist.org